STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more

RegulatoryNeutral

AI Analysis

Summary

A STAT+ Pharmalittle roundup notes the Trump administration is proceeding with a plan to let compounding pharmacies produce certain peptides, alongside other items including Trump's pharma stock holdings. Few additional details are available from the excerpt.

Outcome Details

Trump administration/HHS is proceeding with a plan to allow compounding pharmacies to produce certain peptides.

Importance:4/10

Sentiment:

0.00

HHScompounding pharmaciespeptidesregulatory policyTrump administrationpharma stock holdingsnewsletter roundup

Read the original article

Published by STAT News on October 16, 2026 1:49 PM

Read Original